Evaluation of Patients With Known or Suspected Heart Disease

NCT00001313 | Completed

• 2 other identifiers: 92018992-H-0189
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 2

Brief Summary

In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test. These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.

Conditions

Peripheral Artery Disease; Coronary Disease; Diabetes and Heart Failure; Dilated Cardiomyopathy; Heart Failure; Renal Artery Stenosis; Pulmonary Hypertension

Keywords

Cardiac Diagnosis; Chest Pain; Hypertrophic Cardiomyopathy; Coronary Artery Disease; Microvascular Angina; Cardiac Investigation; Follow-up; Heart Disease

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:
• Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing.
• Cardiomyopathies including congestive phenotypes.
• Peripheral artery disease with intermittent claudication or limb-threatening ischemia.
• Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
• Upper extremity peripheral artery disease.
• Diabetes with heart failure.
• Pulmonary hypertension.

You may not qualify if:

• Pregnancy, for those patients who require catheterization-based diagnostics.
• Inability to provide informed consent.

Sponsors & Collaborators

• National Heart, Lung, and Blood Institute (NHLBI): lead

Study Sites (2)

Suburban Hospital

Bethesda, Maryland, 20814, United States

Location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

MeSH Terms

Conditions

Peripheral Arterial Disease; Coronary Disease; Diabetes Mellitus; Heart Failure; Cardiomyopathy, Dilated; Renal Artery Obstruction; Hypertension, Pulmonary; Chest Pain; Cardiomyopathy, Hypertrophic; Coronary Artery Disease; Microvascular Angina; Heart Diseases

Condition Hierarchy (Ancestors)

Atherosclerosis; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases; Cardiovascular Diseases; Peripheral Vascular Diseases; Myocardial Ischemia; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Cardiomegaly; Cardiomyopathies; Laminopathies; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Lung Diseases; Respiratory Tract Diseases; Hypertension; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Aortic Stenosis, Subvalvular; Aortic Valve Stenosis; Aortic Valve Disease; Heart Valve Diseases; Angina Pectoris

Study Design

• Study Type: observational
• Sponsor Type: NIH

Study Record Dates

• First Submitted: November 3, 1999
• First Posted: November 4, 1999
• Study Start: May 10, 1992
• Study Completion: January 6, 2009
• Last Updated: July 2, 2017

Record last verified: 2009-01-06

Locations

US (2)